-
Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of a NIDA Clinical Trials Network trial.
Tross S, Campbell ANC, Cohen LR, Calsyn DA, Pavlicova M, Miele GM, Hu M, Haynes LF, Nugent N, Gan W, Hatch-Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits-Christoph P, Nunes EV. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of a NIDA Clinical Trials Network trial. Journal of AIDS 2008;48(5):581-589.
-
Adoption of evidence-based practices among substance abuse treatment providers.
Huag NA, Shopshire M, Tajima B, Gruber V, Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. Journal of Drug Education 2008;38(2):181-192.
-
How large must a treatment effect be before it matters to practitioners? An estimation method and demonstration.
Miller WR, Manuel JK. How large must a treatment effect be before it matters to practitioners? An estimation method and demonstration. Drug and Alcohol Review 2008;27(5):524-528
-
Smoking cessation during substance abuse treatment: What you need to know.
Baca CT, Yahne CE. Smoking cessation during substance abuse treatment: What you need to know. Journal of Substance Abuse Treatment 2009;36(2):205-219.
-
A step forward in teaching addiction counselors how to supervise motivational interviewing using a clinical trials training approach.
Martino S, Gallon S, Ball SA, Carroll KM. A step forward in teaching addiction counselors how to supervise motivational interviewing using a clinical trials training approach. Journal of Teaching in the Addictions 2008; 6(2):39-67.
-
Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: A National drug abuse treatment clinical trials network Study.
Wu L, Blazer DG, Stitzer ML, Patkar AA, Blaine J. Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: A National drug abuse treatment clinical trials network Study. American Journal on Addictions 2008;17(4):304-311.
-
Community program therapist adherence and competence in motivational enhancement therapy.
Martino S, Ball SA, Nich C, Frankforter TL, Carroll KM. Community program therapist adherence and competence in motivational enhancement therapy. Drug and Alcohol Dependence 2008;96(1-2):37-48.
-
States and substance abuse treatment programs: Funding and guidelines for infection-related services.
Kritz SA, Brown LS Jr, Goldsmith RJ, Bini EJ, Robinson J, Alderson D, Novo P, Rotrosen J. States and substance abuse treatment programs: Funding and guidelines for infection-related services. American Journal of Public Health 2008;98(5):824-826.
-
Clinical supervision, emotional exhaustion, and turnover intention: A study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse.
Knudsen HK, Ducharme LJ, Roman PM. Clinical supervision, emotional exhaustion, and turnover intention: A study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse. Journal of Substance Abuse Treatment 2008;35(4):387-395.
-
Using a standardized patient walk-through to improve implementation of clinical trials.
Fussell HE, Kunkel LE, Lewy CS, McFarland BH, McCarty D. Using a standardized patient walk-through to improve implementation of clinical trials. Journal of Substance Abuse Treatment 2008;35(4):470-475